Table 3.
NCI-60 five-dose screen, GI50, TGI and LC50 values of bulbillosin A (1) for the respective three most affected cell lines.
| Cell name | Panel name | Concentration (µM) | |
|---|---|---|---|
| GI50 | OVCAR-3 | Ovarian cancer | 1.5 |
| HCT-15 | Colon cancer | 1.5 | |
| HL-60(TB) | Leukemia | 1.6 | |
| TGI | OVCAR-3 | Ovarian cancer | 3.2 |
| HCT-15 | Colon cancer | 3.7 | |
| RPMI-8226 | Leukemia | 6.4 | |
| LC50 | OVCAR-3 | Ovarian cancer | 6.8 |
| HCT-15 | Colon cancer | 11.5 | |
| SK-MEL-28 | Melanoma | 23.3 |